查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1927683

全球基于 CRISPR 的即时诊断市场：按产品类型、技术类型、检测方法、应用、国家和地区划分－产业分析、市场规模、份额和预测（2025-2032 年）

CRISPR-based POC Diagnostics Market, By Product Type, By Technology Type, By Detection Method, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 367 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，基于 CRISPR 的即时诊断市场规模将达到 5.0512 亿美元，从 2025 年到 2032 年的复合年增长率将达到 15.85%。

基于 CRISPR 的照护现场(POC) 技术是一种快速分子检测解决方案，它利用 CRISPR 基因编辑酶以高特异性和灵敏度检测病原体。感染疾病管理领域，特别是呼吸道疾病和新兴感染疾病，对分散式快速诊断的需求日益增长，推动了市场成长。机会包括开发多重和无需仪器的检测方法，从而缩短检测週期，这对于资源匮乏和远端医疗机构至关重要。值得关注的趋势包括将微流体技术与携带式读数器结合，以提高准确性和便利性。然而，监管复杂性、生产扩充性以及缺乏长期临床检验等挑战阻碍了其在常规诊断和大规模筛检计画中的广泛应用。

基于 CRISPR 的即时诊断市场动态

在医疗机构中推广快速、分散式诊断检测的应用

医院、诊所和远端医疗机构对快速、分散式诊断检测的日益普及，推动了基于 CRISPR 技术的照护现场(POC) 技术的需求成长。这些诊断技术在实现及时、准确的疾病检测方面发挥着至关重要的作用。随着医疗系统越来越重视早期诊断、疫情控制和个人化治疗，医疗服务提供者需要能够在中心实验室之外部署的高灵敏度和高特异性检测解决方案。基于 CRISPR 技术的 POC 诊断能够快速检测病原体、遗传标记和传染性病原体，从而满足了此需求，可在患者就诊点或附近进行检测。急诊护理、感染疾病控制和公共卫生监测领域对快速诊断结果的日益依赖，正在加速该技术的应用。尤其是在基层医疗和资源匮乏的环境中，对便携式、易用型诊断工具的需求，促使製造商开发出体积更小、对设备依赖性更低的 CRISPR 平台，同时确保检测的准确性。此外，感染疾病疫情日益频繁的凸显了扩充性、分散式检查解决方案的重要性，进一步推动了市场成长。例如，近期全球健康危机期间快速分子检测的广泛应用，凸显了即时诊断（POC）在减少诊断延误方面的价值。此外，POC检测在筛检、监测和居家照护中的广泛应用，进一步凸显了对可靠、快速且易于使用的基于CRISPR技术的诊断解决方案的迫切需求。

基于 CRISPR 的即时诊断市场：細項分析

全球基于 CRISPR 的即时诊断市场按产品类型、技术类型、检测方法、应用和地区进行细分。

根据产品类型，市场可分为四大类：诊断试剂盒、试剂和酵素、一次性试剂盒以及检测板。诊断试剂盒凭藉其直接的临床应用价值和在照护现场环境中的易用性，占据市场主导。试剂和酵素位居第二，这主要得益于市场对检测方法开发、客製化和重复检测应用（尤其是用于确定灵敏度和特异性的CRISPR相关酶）的持续需求。一次性试剂盒的重要性日益凸显，因为人们越来越关注无污染的单次使用检测形式，这类形式能够简化工作流程，并支持大规模筛检和远端医疗环境中的扩充性。检测板的普及得益于对在单次检测中多重检测多种病原体和生物标记的需求，但其开发复杂性和监管要求目前限制了其广泛应用。总而言之，这些细分市场反映了市场正朝着整合、扩充性且快速的基于CRISPR的即时检测诊断解决方案转变。

根据技术类型，市场可分为四个细分领域：CRISPR-Cas9、CRISPR-Cas12、CRISPR-Cas13 和多重 CRISPR 系统。 CRISPR-Cas12 凭藉其卓越的灵敏度和适用于快速、分散式诊断应用的优势，占据市场主导地位。 CRISPR-Cas13 则位居第二，其优势在于能够标靶化RNA，使其特别适用于检测临床相关的 RNA 病毒和感染疾病。多重 CRISPR 系统由于对在单次检测中同时检测多种病原体或基因靶点的需求日益增长而逐渐普及，但目前检测的复杂性和优化方面的挑战限制了其应用。 CRISPR-Cas9 则位居第二，因为它更应用于基因编辑而非诊断，且缺乏讯号放大功能，因此不适用于快速即时检测应用。总体而言，技术优先级反映了其效能、速度以及与分散式诊断平台整合的便利性。

基于 CRISPR 的即时诊断市场—区域分析

基于CRISPR技术的照护现场（POC）市场在普及率和成长率方面呈现显着的区域差异。北美目前主导全球市场，这得益于其诸多优势，例如先进的医疗基础设施、大量的研发投入以及生物技术公司和学术研究机构的集中，尤其是在美国，这些优势正在加速CRISPR诊断平台的商业化进程。

欧洲占据第二大份额，这得益于强大的公共医疗保健资金、德国、英国和法国等国的合作研究生态系统，以及 CRISPR 检测方法日益融入临床工作流程。

亚太地区预计将实现最高成长率，主要得益于医疗保健支出增加、政府对生物技术创新的支持，以及中国、印度、日本和东南亚地区快速诊断技术的日益普及。

策略性产业趋势支撑着该地区的发展势头，例如印度生物技术公司 CrisprBits 与 Molbio Diagnostics 建立战略合作伙伴关係，开发和商业化 POC CRISPR 测试，提高其在区域和全球市场的可及性。

基于 CRISPR 的即时诊断市场—国家分析

基于 CRISPR 的即时诊断 (POC) 市场在国家层面的发展趋势反映了医疗政策重点、投资环境和创新生态系统的差异。美国凭藉强大的生物技术研发资金、对新型诊断技术的监管支持以及 CRISPR 平台的早期商业化，在全球处于领先地位，从而获得了较高的市场份额并在临床环境中得到广泛应用。在欧洲，德国、英国和法国等国家的成长速度仅次于美国，这得益于合作研究网路以及与寻求快速、准确诊断工具的医疗系统的整合。亚太市场，尤其是中国、印度和日本，由于感染疾病负担日益加重、生物技术投资不断增长以及医疗基础设施的不断完善，正经历着快速的市场扩张，预计这将推动这些国家快速采用 CRISPR 即时诊断技术。

策略性倡议包括 OraSure Technologies 收购美国 Sherlock Biosciences，这将扩大其 CRISPR 诊断产品；以及 CrisprBits 与印度 Molbio Diagnostics 建立战略合作伙伴关係，共同开发和部署面向国内和国际市场的 POC CRISPR 测试。

目录

第一章 CRISPR技术即时诊断市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章 基于CRISPR技术的即时诊断市场主要趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

4. 基于 CRISPR 的即时诊断市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

5. 基于 CRISPR 的即时诊断市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：基于CRISPR技术的即时诊断市场概况

  • 基于 CRISPR 的即时诊断市场份额分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

7. 基于 CRISPR 的即时诊断市场（按产品类型划分）

  • 概述
    • 细分市场占有率分析：依产品类型
    • 诊断试剂盒
    • 试剂和酶
    • 免洗墨水匣
    • 检测组

8. 基于 CRISPR 的即时诊断市场（按技术类型划分）

  • 概述
    • 细分市场占有率分析：依技术类型划分
    • CRISPR-Cas9
    • CRISPR-Cas12
    • CRISPR-Cas13
    • 多重CRISPR系统

9. 基于 CRISPR 的即时诊断市场（按检测方法划分）

  • 概述
    • 细分市场占有率分析：依检测方法
    • 基于萤光的检测
    • 比色检测
    • 电化学检测
    • 侧向流动检测

10. 基于 CRISPR 的即时诊断市场（按应用划分）

  • 概述
    • 细分市场占有率分析：按应用
    • 感染疾病检测
    • 遗传疾病筛检
    • 肿瘤诊断
    • 抗生素抗药性检测

11. 各地区基于 CRISPR 的即时诊断市场

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十二章 主要供应商分析－基于 CRISPR 的即时诊断产业

  • 竞争格局分析
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Abbott Laboratories
    • Agilent Technologies
    • AstraZeneca
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories
    • Caspr Biotech
    • Danaher Corporation
    • Detect Inc.
    • Hologic
    • Illumina
    • Lucira Health
    • Mammoth Biosciences
    • Merck KGaA
    • Qiagen
    • QuidelOrtho
    • Roche Diagnostics
    • Sherlock Biosciences
    • Siemens Healthineers
    • Thermo Fisher Scientific
    • Twist Bioscience
    • Others

第十三章：分析师视角360度分析

简介目录
Product Code: ANV5957

CRISPR-based POC Diagnostics Market size was valued at US$ 505.12 Million in 2024, expanding at a CAGR of 15.85% from 2025 to 2032.

CRISPR-based point-of-care (POC) diagnostics are rapid molecular testing solutions that leverage CRISPR gene-editing enzymes for highly specific and sensitive detection of pathogens. Rising demand for decentralized, fast diagnostics in infectious disease management, particularly for respiratory and emerging diseases, is driving market growth. Opportunities lie in developing multiplexed and instrument-free assays with shorter turnaround times, essential for use in low-resource and remote healthcare settings. A prominent trend is the integration of CRISPR diagnostics with microfluidics and portable readers to enhance accuracy while improving usability. However, challenges such as regulatory complexity, scalability of manufacturing, and limited long-term clinical validation restrain widespread adoption in routine diagnostics and large-scale screening programs.

CRISPR-based POC Diagnostics Market- Market Dynamics

Increasing adoption of rapid, decentralized diagnostic testing across healthcare settings

The increasing adoption of rapid, decentralized diagnostic testing across hospitals, clinics, and remote healthcare settings is significantly driving demand for CRISPR-based point-of-care (POC) diagnostics, which play a critical role in enabling timely and accurate disease detection. As healthcare systems place greater emphasis on early diagnosis, outbreak control, and personalized treatment, providers require highly sensitive and specific testing solutions that can be deployed outside centralized laboratories. CRISPR-based POC diagnostics address this need by enabling rapid molecular detection of pathogens, genetic markers, and infectious agents at or near the patient site. The growing reliance on fast-turnaround diagnostics in emergency care, infectious disease management, and public health surveillance is accelerating adoption. In particular, the demand for portable and easy-to-use diagnostic tools in primary care and low-resource settings is pushing manufacturers to develop compact, instrument-light CRISPR platforms without compromising accuracy. Moreover, the rising frequency of infectious disease outbreaks has highlighted the importance of scalable and decentralized testing solutions, further supporting market growth. For instance, increased use of rapid molecular tests during recent global health emergencies demonstrated the value of point-of-care diagnostics in reducing diagnostic delays. Additionally, the expanding use of POC testing in screening, surveillance, and home-based care is reinforcing the need for reliable, fast, and user-friendly CRISPR-based diagnostic solutions.

CRISPR-based POC Diagnostics Market- Segmentation Analysis:

The Global CRISPR-based POC Diagnostics Market is segmented on the basis of Product Type, Technology Type, Detection Method, Application, and Region.

The market is segmented into four categories based on product type: diagnostic kits, reagents & enzymes, disposable cartridges, and assay panels. Among these, the diagnostic kits segment dominates the market due to its direct clinical applicability and ease of use in point-of-care settings. Reagents & Enzymes rank second, driven by continuous demand from assay development, customization, and repeated test usage, particularly CRISPR-associated enzymes that determine sensitivity and specificity. Disposable Cartridges follow, gaining importance due to rising emphasis on contamination-free, single-use testing formats that simplify workflows and support scalability in mass screening and remote healthcare environments. Assay Panels rank next, as their adoption is growing with demand for multiplex detection of multiple pathogens or biomarkers in a single test, though higher development complexity and regulatory requirements currently limit widespread uptake. Collectively, these segments reflect a shift toward integrated, scalable, and rapid CRISPR-based POC diagnostic solutions.

The market is categorized into four segments based on technology type: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, and multiplex CRISPR systems. The CRISPR-Cas12 segment leads the market, driven by its superior sensitivity and suitability for rapid, decentralized diagnostic applications. CRISPR-Cas13 ranks second, driven by its RNA-targeting capability, making it particularly suitable for detecting RNA viruses and infectious diseases with high clinical relevance. Multiplex CRISPR Systems follow, gaining traction as demand increases for simultaneous detection of multiple pathogens or genetic targets in a single test, although assay complexity and optimization challenges currently moderate adoption. CRISPR-Cas9 ranks next, as it is more widely used in gene editing than diagnostics and lacks inherent signal amplification features, limiting its suitability for rapid POC applications. Overall, technological prioritization reflects performance, speed, and ease of integration into decentralized diagnostic platforms.

CRISPR-based POC Diagnostics Market- Geographical Insights

The CRISPR-based point-of-care (POC) diagnostics market exhibits significant regional variation in adoption and growth rates. North America currently dominates the global landscape, benefiting from advanced healthcare infrastructure, substantial R&D investment, and a strong concentration of biotechnology companies and academic research institutions, particularly in the United States, which accelerates the commercialization of CRISPR diagnostic platforms.

Europe holds the second-largest share, supported by robust public health funding, collaborative research ecosystems in countries such as Germany, the UK, and France, and increasing integration of CRISPR assays into clinical workflows.

The Asia-Pacific region is projected to experience the fastest growth rate, driven by rising healthcare expenditure, government support for biotechnology innovation, and expanding use of rapid diagnostics across China, India, Japan, and Southeast Asia.

Strategic industry developments underscore regional momentum. For instance, Indian biotech firm CrisprBits entered a strategic collaboration with Molbio Diagnostics to develop and commercialize POC CRISPR tests, enhancing accessibility in local and global markets.

CRISPR-based POC Diagnostics Market- Country Insights

Country-level dynamics in the CRISPR-based point-of-care (POC) diagnostics market reflect differing healthcare priorities, investment climates, and innovation ecosystems. The United States leads globally, driven by strong biotech R&D funding, regulatory support for novel diagnostics, and early commercialization of CRISPR platforms, resulting in significant market share and adoption in clinical settings. Europe, with countries such as Germany, the United Kingdom, and France, follows closely, supported by collaborative research networks and integration into healthcare systems seeking rapid, accurate diagnostic tools. Asia-Pacific markets, notably China, India, and Japan, are fast expanding due to rising infectious disease burdens, increased biotech investment, and growing healthcare infrastructure, positioning these nations for rapid POC CRISPR adoption.

Strategic developments include the acquisition of Sherlock Biosciences by OraSure Technologies in the US to broaden CRISPR diagnostic offerings, and a strategic collaboration between India's CrisprBits and Molbio Diagnostics to co-develop and deploy POC CRISPR tests domestically and internationally.

CRISPR-based POC Diagnostics Market- Competitive Landscape:

The competitive landscape of the CRISPR-based point-of-care (POC) diagnostics market is characterized by rapid innovation, strategic partnerships, and consolidation among key biotechnology and diagnostics firms. Leading players such as Mammoth Biosciences, OraSure Technologies (via Sherlock Biosciences), Caspr Biotech, Integrated DNA Technologies (IDT), and GenScript are actively developing and commercializing CRISPR-based diagnostic platforms that combine high sensitivity with decentralized usability. Competitive differentiation is achieved through assay performance, patent portfolios, and integration with portable devices. Market activity includes acquisitions that strengthen technological capabilities and accelerate time-to-market; notably, Sherlock Biosciences acquired Sense Bio detection to integrate instrument-free molecular test hardware with its CRISPR technology, broadening its point-of-care portfolio.

Collaborations also enhance competitiveness, such as strategic alliances between CrisprBits and Molbio Diagnostics to co-develop and distribute rapid POC tests, expanding market reach and accelerating adoption in diverse healthcare settings.

Recent Developments:

In August 2023, CrisprBits entered a strategic collaboration with Molbio Diagnostics to jointly develop and launch CRISPR-based point-of-care (POC) tests, combining CrisprBits' PathCrisp platform with Molbio's manufacturing and distribution network to deliver rapid, affordable diagnostics globally.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Agilent Technologies
  • AstraZeneca
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Caspr Biotech
  • Danaher Corporation
  • Detect Inc.
  • Hologic
  • Illumina
  • Lucira Health
  • Mammoth Biosciences
  • Merck KGaA
  • Qiagen
  • QuidelOrtho
  • Roche Diagnostics
  • Sherlock Biosciences
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Twist Bioscience
  • Others

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Kits
  • Reagents & Enzymes
  • Disposable Cartridges
  • Assay Panels

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • CRISPR-Cas9
  • CRISPR-Cas12
  • CRISPR-Cas13
  • Multiplex CRISPR Systems

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY DETECTION METHOD- MARKET ANALYSIS, 2019 - 2032

  • Fluorescence-Based Detection
  • Colorimetric Detection
  • Electrochemical Detection
  • Lateral Flow Readout

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease Detection
  • Genetic Disorder Screening
  • Oncology Diagnostics
  • Antimicrobial Resistance Testing

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CRISPR-based POC Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CRISPR-based POC Diagnostics Market Snippet by Product Type
    • 2.1.2. CRISPR-based POC Diagnostics Market Snippet by Technology Type
    • 2.1.3. CRISPR-based POC Diagnostics Market Snippet by Detection Method
    • 2.1.4. CRISPR-based POC Diagnostics Market Snippet by Application
    • 2.1.5. CRISPR-based POC Diagnostics Market Snippet by Country
    • 2.1.6. CRISPR-based POC Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. CRISPR-based POC Diagnostics Key Market Trends

  • 3.1. CRISPR-based POC Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CRISPR-based POC Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CRISPR-based POC Diagnostics Market Opportunities
  • 3.4. CRISPR-based POC Diagnostics Market Future Trends

4. CRISPR-based POC Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CRISPR-based POC Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CRISPR-based POC Diagnostics Market Landscape

  • 6.1. CRISPR-based POC Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CRISPR-based POC Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Diagnostic Kits
    • 7.1.3. Reagents & Enzymes
    • 7.1.4. Disposable Cartridges
    • 7.1.5. Assay Panels

8. CRISPR-based POC Diagnostics Market - By Technology Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology Type, 2024 & 2032 (%)
    • 8.1.2. CRISPR-Cas9
    • 8.1.3. CRISPR-Cas12
    • 8.1.4. CRISPR-Cas13
    • 8.1.5. Multiplex CRISPR Systems

9. CRISPR-based POC Diagnostics Market - By Detection Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Detection Method, 2024 & 2032 (%)
    • 9.1.2. Fluorescence-Based Detection
    • 9.1.3. Colorimetric Detection
    • 9.1.4. Electrochemical Detection
    • 9.1.5. Lateral Flow Readout

10. CRISPR-based POC Diagnostics Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Infectious Disease Detection
    • 10.1.3. Genetic Disorder Screening
    • 10.1.4. Oncology Diagnostics
    • 10.1.5. Antimicrobial Resistance Testing

11. CRISPR-based POC Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. CRISPR-based POC Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. CRISPR-based POC Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. CRISPR-based POC Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. CRISPR-based POC Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. CRISPR-based POC Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- CRISPR-based POC Diagnostics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Agilent Technologies
    • 12.2.3. AstraZeneca
    • 12.2.4. Becton, Dickinson and Company
    • 12.2.5. Bio-Rad Laboratories
    • 12.2.6. Caspr Biotech
    • 12.2.7. Danaher Corporation
    • 12.2.8. Detect Inc.
    • 12.2.9. Hologic
    • 12.2.10. Illumina
    • 12.2.11. Lucira Health
    • 12.2.12. Mammoth Biosciences
    • 12.2.13. Merck KGaA
    • 12.2.14. Qiagen
    • 12.2.15. QuidelOrtho
    • 12.2.16. Roche Diagnostics
    • 12.2.17. Sherlock Biosciences
    • 12.2.18. Siemens Healthineers
    • 12.2.19. Thermo Fisher Scientific
    • 12.2.20. Twist Bioscience
    • 12.2.21. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us